Vascular Resection During Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms (PanNENs): a Comparative Single Centre Study
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 40
- 主要终点
- Progression-Free Survival
研究概览
简要总结
The limited evidence on the value of portal vein resection in patients with borderline resectable and/or locally advanced PanNENs is an incentive to carry out a retrospective multicentre study amongst centres with specific interest in the management of PanNENs and with experience on vascular reconstruction. Unlike previous studies on pancreatic cancer, it is more difficult to standardise the comparative parameters as the definition of borderline resectable disease has never been published for PanNENs. Similarly, different histological classifications make impossible to collect data exclusively on T3 tumours. Therefore, we aim to compare the short and long-term outcomes (including the impact of the histological depth of vascular invasion on survival) between patients undergoing standard PD and PD with portal vein resection for PanNENs, (regardless of T stage), by collecting and analysing retrospective data in this single centre study
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All patients undergoing pancreaticoduodenectomy (Whipple's or Pylorus Preserving Pancreaticoduodenectomy) for sporadic PanNENs of the head of the pancreas of any stage (R0 or R1 resections) operated from 1st January 2007 up to 31st December 2016 inclusive.
排除标准
- •Multiple Neuroendocrine Neoplasia (MEN) syndrome or other genetic background
- •Age <18 years old
- •Total pancreatectomy or different operation rather than PD
- •R2 Resections
结局指标
主要结局
Progression-Free Survival
时间窗: total of 2 years retrospective follow up
Time from surgery to disease progression, or death or completion of follow up
次要结局
- Histology predictive value(total of 2 years retrospective follow up)
- Morbidity and mortality rate(total of 2 years retrospective follow up)
